Abdelmohsen Usama Ramadan, Yang Chen, Horn Hannes, Hajjar Dina, Ravasi Timothy, Hentschel Ute
Department of Botany II, Julius-von-Sachs Institute for Biological Sciences, University of Würzburg, Julius-von-Sachs-Platz 3, Würzburg D-97082, Germany.
Division of Chemical & Life Sciences and Engineering and Division of Applied Mathematics and Computer Science, King Abdullah University of Science and Technology, Thuwal 23955-6900, Saudi Arabia.
Mar Drugs. 2014 May 12;12(5):2771-89. doi: 10.3390/md12052771.
The diversity of actinomycetes associated with marine sponges collected off Fsar Reef (Saudi Arabia) was investigated in the present study. Forty-seven actinomycetes were cultivated and phylogenetically identified based on 16S rRNA gene sequencing and were assigned to 10 different actinomycete genera. Eight putatively novel species belonging to genera Kocuria, Mycobacterium, Nocardia, and Rhodococcus were identified based on sequence similarity values below 98.2% to other 16S rRNA gene sequences available in the NCBI database. PCR-based screening for biosynthetic genes including type I and type II polyketide synthases (PKS-I, PKS-II) as well as nonribosomal peptide synthetases (NRPS) showed that 20 actinomycete isolates encoded each at least one type of biosynthetic gene. The organic extracts of nine isolates displayed bioactivity against at least one of the test pathogens, which were Gram-positive and Gram-negative bacteria, fungi, human parasites, as well as in a West Nile Virus protease enzymatic assay. These results emphasize that marine sponges are a prolific resource for novel bioactive actinomycetes with potential for drug discovery.
本研究调查了从沙特阿拉伯的法萨尔礁采集的与海洋海绵相关的放线菌的多样性。培养了47株放线菌,并基于16S rRNA基因测序进行系统发育鉴定,将它们归为10个不同的放线菌属。基于与NCBI数据库中其他16S rRNA基因序列的相似性值低于98.2%,鉴定出8个可能属于考克氏菌属、分枝杆菌属、诺卡氏菌属和红球菌属的新物种。基于聚合酶链反应(PCR)对包括I型和II型聚酮合酶(PKS-I、PKS-II)以及非核糖体肽合成酶(NRPS)在内的生物合成基因进行筛选,结果表明20株放线菌分离株各自至少编码一种生物合成基因。9株分离株的有机提取物对至少一种测试病原体具有生物活性,这些病原体包括革兰氏阳性菌和革兰氏阴性菌、真菌、人体寄生虫,以及在西尼罗河病毒蛋白酶酶活性测定中。这些结果强调,海洋海绵是具有药物发现潜力的新型生物活性放线菌的丰富资源。